|
Match
|
Document |
Document Title |
|
|
8158133 |
Pharmaceutical composition useful for vaccines
A pharmaceutical composition including at least a mixture of at least one oil, at least one surfactant and an aqueous phase, itself including at least one active substance, the pharmaceutical...
|
|
|
8097239 |
Controlled-release formulations
The present invention relates to formulations of a lipid based controlled-release matrix, a polyhydroxy component and a bioactive agent. Such formulation are useful in the delivery of the bioactive...
|
|
|
8092813 |
Polychlorinated biphenyls and squalene-containing adjuvants
When using squalene in a vaccine adjuvant, there is a possibility of contamination with polychlorinated biphenyls (PCBs). Environmental exposure to PCBs may adversely affect children's immune...
|
|
|
8063020 |
Resuscitation fluid
A method for treating conditions related to lack of blood supply with a lipid based resuscitation fluid is disclosed. The resuscitation fluid contains a lipid component and an aqueous carrier. The...
|
|
|
7943154 |
Method for producing multiple emulsions that are stable in storage
A process is described for the preparation of storage-stable, multiple emulsions of the water/oil/water (W/O/W) type which comprise one or more active ingredients. The process comprises the steps...
|
|
|
7943588 |
Method for preventing or treating neuropathic pain
The present invention is a method for preventing or treating neuropathic pain. Using an agent to decrease the expression or activity of Toll-like receptor 4 (TLR4), behavioral hypersensitivity is...
|
|
|
7906122 |
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
The present invention concerns the use of a sphingoid-polyalkylamine conjugate as a capturing agent of biologically active molecules, such as antigens. In a particular embodiment, the...
|
|
|
7871631 |
Methods of inhibiting the lowering of antihuman TNF-α antibody
The present invention provides an antihuman TNF-α antibody activity lowering inhibitor comprising a protein source(s) and/or carbohydrate source(s), in the treatment of inflammatory bowel syndrome ...
|
|
|
7850973 |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, such as Alzheimer's disease. Such methods entail ...
|
|
|
7838019 |
Composition comprising iscom particles and live micro-organisms
Iscom particles can be used as an adjuvant for preparing of an antigenic composition which comprises live micro-organisms and/or killed micro-organisms and/or antigenic molecules. A composition may...
|
|
|
7824686 |
Vaccines with enhanced immune response and methods for their preparation
The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen...
|
|
|
7815920 |
Method of preparing an antigen-containing formulation
An antigen-containing formulation is provided, comprising: (a) an antigen; (b) a TH1-inducing adjuvant; and (c) a sparingly soluble amino acid or a derivative thereof. The adjuvant may be, for...
|
|
|
7776324 |
Cancer vaccine
The present invention relates to a method for producing a composition for use as a vaccine for treatment or prevention of cancer. The method includes the steps of isolating dendritic cells from a...
|
|
|
7749520 |
Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
The present invention relates to liposome formulations that are physically stable. In particular the present invention relates to steric stabilization of cationic liposomes by incorporating...
|
|
|
7727973 |
Lipid A-type compound and composition containing it
Compounds of the formula: and compositions containing one or more such compounds, the compositions preferably being suitable for topical application to the skin.
|
|
|
7713942 |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
The present invention pertains to complexes comprising sterols and saponins. The complexes are capable of binding a genetic determinant including a polynucleotide. The complexes may further...
|
|
|
7666447 |
Compositions including Krill extracts and conjugated linoleic acid and methods of using same
Methods and compositions for the prevention, therapy and/or treatment of several disease states. The methods comprise the administration of a therapeutically effective amount of a composition...
|
|
|
7648705 |
Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine
The present invention provides a safe and effective vaccine composition against West Nile virus disease. An immunogenically active component of West Nile virus or plasmid DNA, an adjuvant such as a...
|
|
|
7648706 |
West nile DNA vaccine
The present invention provides a safe and effective vaccine composition against West Nile virus disease. An immunogenically active component of West Nile virus or plasmid DNA, an adjuvant such as a...
|
|
|
7641911 |
Immunological adjuvant compositions
The present invention is directed to novel adjuvant compositions, which target the cellular and/or humoral arms of immunity. According to an embodiment of the invention, an oil-in-water adjuvant...
|
|
|
7638314 |
Production of biodiesel and other valuable chemicals from wastewater treatment plant sludges
A process for producing biodiesel has been invented by first extracting lipids from the sludges generated during primary and/or biological treatment of municipal, agricultural, and industrial...
|
|
|
7608246 |
Apolipoprotein E as an adjuvant for lipid antigens
The present invention is directed to pharmaceutical compositions that contain a combination of apolipoprotein E and an antigenic lipid. The compositions may be administered to a subject for the...
|
|
|
7563446 |
Methods and compositions for inducing autoimmunity in the treatment of cancers
Disclosed are methods and compositions for the prevention and treatment of cancers using lipid-carrier protein conjugate compositions for generating lipid-specific immune responses in an animal....
|
|
|
7534443 |
Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
An oil-in-water emulsion that comprise a bacterial component as an active ingredient as well as essentially an oil, surfactant, and a stabilizer, and that can be used as an agent for immunotherapy,...
|
|
|
7517953 |
Pasteurisation process for microbial cells and microbial oil
An improved pasteurization protocol for pasteurizing microbial cells is disclosed. The protocol has three stages, a first heating stage, a second plateau stage at which the cells are held at a...
|
|
|
7381422 |
Method for producing sterile polynucleotide based medicaments
The present invention relates to a novel method for producing formulations comprising a polynucleotide, block copolymer and cationic surfactant. The formulations produced by the current method are...
|
|
|
7374751 |
QS-21 and IL-12 as an adjuvant combination
Adjuvant compositions comprising an effective amount IL-12 and QS-21 are disclosed. Immunogenic, vaccine and pharmaceutical compositions comprising a mixture of antigen and an adjuvant composition...
|
|
|
7371395 |
Vaccine formulations
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified or...
|
|
|
7357936 |
Adjuvant systems and vaccines
The present invention provides vaccine and adjuvant formulation comprising an immunostimulant and a metal salt. The immunostimulant is adsorbed onto a particle of metal salt and the resulting...
|
|
|
7329410 |
Compositions and method for WT1 specific immunotherapy
A method for enhancing or inducing an immune response to WT1 is disclosed. In particular, the method comprises administering to a patient an immunogenic composition comprising an isolated...
|
|
|
7309493 |
Inactivated bovine scours vaccines, process and method of preventing bovine scours
Inactivated scours vaccines for immunization and protection of bovine animals from disease caused by infection with bovine rotavirus and bovine coronavirus, which comprise and effective amount of...
|
|
|
7276579 |
Immunogenic proteoliposomes, and uses thereof
An immunogenic proteoliposome containing a transmembrane protein or oligomeric complexes containing such proteins, including viral envelope glycoproteins, in a lipid membrane around an elliptoid or...
|
|
|
7259012 |
Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cells
The invention concerns a method for differentiating precursor cells into mature dendritic cells, comprising placing the precursor cells in a medium suitable for their differentiation and adding to...
|
|
|
7255867 |
Vaccine
Effective stimulation of immune responses is achieved through the use of a group A streptococcal antigen combined with proteosome adjuvant. The compositions are provided in particular for...
|
|
|
7223739 |
Adjuvanted genetic vaccines
Reagents useful in nucleic acid immunization techniques are described. More particularly, adjuvanted genetic vaccine compositions are described, as are methods of using those compositions for...
|
|
|
7189418 |
Method for extracting lipid mixture containing phospholipids comprising polyunsaturated fatty acids from viscera of fish, method for preserving viscera prior to extraction, and lipid mixture extracted thereby
The present invention provides a method for extracting a lipid mixture having a high percentage of phospholipids comprising polyunsaturated fatty acids. The method comprises the steps of (a)...
|
|
|
7147862 |
Vaccine composition containing adjuvants
The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and γ IFN responses.
|
|
|
7122191 |
Microfluidized oil-in-water emulsions and vaccine compositions
This invention provides submicron oil-in-water emulsions useful as a vaccine adjuvant for enhancing the immunogenicity of antigens. The present invention also provides vaccine compositions...
|
|
|
7078388 |
DNA vaccines for farm animals, in particular bovines and porcines
DNA vaccine against a pathogen affecting farm animals, in particular bovines or porcines, comprising a plasmid containing a nucleotide sequence encoding an immunogen of a pathogen of the animal...
|
|
|
7063855 |
Composition for feeding prey organisms in aquaculture
A composition is for feeding aquacultural prey organisms such as Artemia and rotifiers, comprising a lipid component comprising at least 25 wt % of phospholipids and providing a DHA content of at...
|
|
|
7052704 |
Methods and compositions for lipidization of hydrophilic molecules
Fatty acid derivatives of sulfhydryl-containing compounds (for example, sulfhydryl-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage are employed...
|
|
|
7033612 |
Composition and method for treating age-related disorders
There is provided a composition for the prevention and treatment of age-related physical and mental disorders that includes phospholipids that have been extracted from chick embryos aged between...
|
|
|
6974577 |
Inactivated bovine scours vaccines, processes and method of preventing bovine scours
Inactivated scours vaccines for immunization and protection of bovine animals from disease caused by infection with bovine rotavirus and bovine coronavirus, which comprise and effective amount of...
|
|
|
6951658 |
Emu-based compositions for mental well-being and method of use
The invention is a method and supplement for treatment of symptoms of Alzheimer's disease, dementia, depression, and combination thereof, comprising: from about 20 wt % to about 70 wt % emu oil,...
|
|
|
6936260 |
Vaccine composition
A tuberculosis (TB) vaccine composition is disclosed. The composition comprises, as adjuvant, one or more substances selected from a) monoglyceride preparations having at least 80% monoglyceride...
|
|
|
6932972 |
Combined vaccine compositions
Novel combined vaccine composition preferentially for administration to adolescents are provided, comprising a hepatitis B viral antigen and a herpes simplex viral antigen and optionally in...
|
|
|
6919084 |
Duck pneumovirus and corresponding vaccines
An immunogenic preparation or vaccine against avian pneumovirosis, comprising an antigen of the avian pneumovirus strain C990427, in a vehicle or excipient which is acceptable from the veterinary...
|
|
|
6896888 |
Treatment of papilloma virus infection using a mycobacterium
Disease cased by papilloma virus is treated by applying an effective amount of Mycobacterium to the region of infection. Specifically, condylomata acuminata are caused by human papilloma virus...
|
|
|
6893644 |
Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A
A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier...
|
|
|
6890540 |
Vaccine formulation
A vaccine formulation against a microorganism is disclosed. The formulation comprises: as adjuvant, one or more substances selected from a) monoglyceride preparations having at least 80%...
|